Dronedarone in High-Risk Permanent Atrial Fibrillation

J. Connolly, Stuart; John Camm, A.; L. Halperin, Jonathan; Joyner, Campbell; Alings, Marco; Amerena, John; Atar, Dan; Avezum, Álvaro; Blomström, Per; Borggrefe, Martin; Budaj, Andrzej; Chen, Shih-Ann; Keong Ching, Chi; Commerford, Patrick; Dans, Antonio; Davy, Jean-Marc; Delacrétaz, Etienne; Di Pasquale, Giuseppe; Diaz, Rafael; Dorian, Paul; Flaker, Greg; Golitsyn, Sergey; Gonzalez-Hermosillo, Antonio; B. Granger, Christopher; Heidbüchel, Hein; Kautzner, Josef; Soo Kim, June; Lanas, Fernando; S. Lewis, Basil; L. Merino, Jose; Morillo, Carlos; Murin, Jan; Narasimhan, Calambur; Paolasso, Ernesto; Parkhomenko, Alexander; S. Peters, Nicholas; Sim, Kui-Hian; K. Stiles, Martin; Tanomsup, Supachai; Toivonen, Lauri; Tomcsányi, János; Torp-Pedersen, Christian; Tse, Hung-Fat; Vardas, Panos; Vinereanu, Dragos; Xavier, Denis; Zhu, Jun; Zhu, Jun-Ren; Baret-Cormel, Lydie; Weinling, Estelle; Staiger, Christoph; Yusuf, Salim; Chrolavicius, Susan; Afzal, Rizwan; H. Hohnloser, Stefan

doi:10.1056/nejmoa1109867

Public

Dronedarone in High-Risk Permanent Atrial Fibrillation

Published in New England Journal of Medicine • Nov 14, 2011

Authors:

Stuart J. Connolly

A. John Camm

Jonathan L. Halperin

Abstract

BACKGROUND: Dronedarone restores sinus rhythm and reduces hospitalization or death in intermittent atrial fibrillation. It also lowers heart rate and blood pressure and has antiadrenergic and potential ventricular antiarrhythmic effects. We hypothesized that dronedarone would reduce major vascular e...

Subject

Dronedarone

Medicine

Cardiology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!